Back to All

Webinar: Is Pharma Leveraging the Diagnostic in Targeted Therapy Branding and Communications?

1 June, 2016

Targeted therapy communications present a host of new opportunities and challenges for brand teams. Research has shown that positive diagnostic sentiment among consumers can be leveraged to enhance and optimize targeted therapy communications. But until now no reports have studied the communication styles pharma has used in targeted therapy communications. This webinar, led by the Bioceutics team, provides an analysis of targeted therapy communications looking at pharma communication styles, positioning and strategies. It draws insight from the Bioceutics Personalized Healthcare Brand Index Surveillance Report, a first of its kind study of targeted therapies in the marketplace. Listen to this webinar to learn:

  • An analysis of targeted therapy communications looking at communication styles, positioning and strategies
  • The key drivers in taking a particular communications path
  • What's working and what's not working
  • Real world examples and learnings

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.

Public Relations & Investor Relations advisers

Alma PR
71-73 Carter Lane

Tel: +44 (0)20 3405 0205 or [email protected]

Caroline Forde
Robyn Fisher
Kieran Breheny